S T A N F O R D M E D I C I N E

Winter 1999/2000

 

For Alumni
Stanford
MD

 

On the Cover

Deep Brain Stimulation: Healing Neurological Disorders. 

Cover illustration by San Francisco-based artist Jeffrey Decoster.

Stanford Medicine, published quarterly by Stanford University Medical Center, aims to keep readers informed about the education, research, clinical care and other goings on at the Medical Center.

 

Desisting Twisting

Ruthann Richter

 

Deep brain stimulation allows people with dystonia to unwind.

 

When scientists began using deep brain stimulation (DBS) in patients with Parkinson's disease, they noticed these patients were no longer forced into twisted, contorted positions -- a common side effect of Parkinson's known as dystonia.

Some 50,000 children in North America are born each year with a severe, genetic form of dystonia, which shows up in the first or second decade of life. These young patients can become torqued in unnatural postures and have to be fitted with rods in their spines to keep them semi-erect. Those with advanced disease may become wheelchair-bound or bedridden.

After noticing that dystonia symptoms subsided with use of DBS in Parkinson's patients, doctors began to consider applying the technique in patients with the genetic form of the disease, says Helen Bronte-Stewart, MD, director of the Stanford Comprehensive Movement Disorders Center. They reasoned that these patients would benefit from the same treatment: electrical stimulation of the part of the brain known as the globus pallidum.

"They found that the dystonia of Parkinson's was cured with this target and they thought they should try it in people with genetic dystonia -- and it has worked. The results are quite remarkable," says Bronte-Stewart, who is an assistant professor of neurology.

In the past two years, Bronte-Stewart has treated two dystonia patients and is working with three or four others who are potential candidates for the procedure, she says. A videotape of her first two patients shows a young man and a young woman literally transformed from hunched, twisted figures to individuals with no apparent disability.

One patient, a man in his 20s, was unable to walk before the surgery, his head bent low and his arms curled about his torso. After DBS on one side of the brain, the slender, red-haired patient walked with a cane down the clinic halls and his body had only a slight twist to it. After a second surgery, on the other side, he strode into the clinic and then broke into a run, smiling at his caregivers.

The same results are apparent in a second patient, a 23-year-old woman, who was wary of DBS and chose instead to have a pallidotomy, a treatment in which doctors destroy cells in the globus pallidum that cause dystonia. Bronte-Stewart says cell destruction and stimulation both can achieve similar effects. A pallidotomy performed on both sides of the brain, however, can be somewhat risky, as the accidental destruction of nearby cells can leave patients with speech and swallowing problems, she says.

In the young woman's case, the surgery went remarkably well. When she arrived at the clinic for her first visit, she was completely bent over and unable to hold her head up without propping it up with her hands. Her body was twisted in an awkward posture. After a pallidotomy, performed in April on the right side of her brain, the trembling in her left hand disappeared and she had better use of her left arm and leg, although her right side remained slightly twisted. Her right side still dragged her down.

Four days after the surgery on her left side, she strolled upright into the clinic with no signs of any difficulty. She now attends college and is doing well, Bronte-Stewart says.

Bronte-Stewart notes that it was by happenstance -- not by rigorous science -- that doctors chose the globus pallidum as a DBS target for these dystonia patients.

"It isn't based on any careful analysis of which place we should quiet down," she says.

Bronte-Stewart is now in the process of establishing a deep brain recording unit at Stanford, in which she and colleagues will systematically test patients with the goal of identifying the best sites and best methods for electrical stimulation.

Identifying which areas of the brain are abnormal also could be useful to geneticists, who have been tracking the molecular pathways of the disease. The gene for early onset dystonia, known as DYT1, was identified in 1997 by a team that included Neil Risch, PhD, a professor of genetics at Stanford. ­ RUTHANN RICHTER

Related articles:

Moving with the Current